The licensing and use information on this page applies to both the Lung Cancer Symptom Scale (LCSS) and the Lung Cancer Symptom Scale–Mesothelioma (LCSS-Meso) unless otherwise noted.
Choose the category that fits your study
For-Profit Sponsored Research
For a clinical trial or study sponsored by a for-profit organization, such as a pharmaceutical, biotechnology, medical device or other commercial company.
Licensing is based on enrolled patients, participating study sites and language versions required.
Not-for-Profit Sponsored Research
For a clinical trial or study supported by a not-for-profit source, such as a federal or university grant, nonprofit organization or philanthropic foundation.
The license includes the English version and one additional language version of the applicable instrument.
Unsponsored Research & Special Use
For studies without a sponsor, smaller investigator-initiated research, special uses, or researchers who may need financial assistance.
Reduced-fee waiver requests may be considered based on circumstances.
Not sure which category applies?
Review the complete fee schedule and licensing terms, or contact QLRA for assistance.
View Current Licensing Fees & User AgreementContact UsImportant use requirements
One license, one study
A license for an LCSS instrument applies to a single clinical trial or study. A new licensing agreement is required for each additional study.
Preserve the validated instrument
The LCSS and LCSS-Meso must be used in their approved formats and may not be modified or altered. The content, response scales, format and proportions of the applicable instrument must be maintained to ensure that patient responses can be accurately measured and scored.
Digital use is permitted
The LCSS instruments may be presented electronically on a tablet, phone, computer or other digital platform, provided that the content, response scales, format and proportions remain consistent with the approved instrument.
Questions about implementation?
Please contact QLRA before modifying, resizing or adapting an instrument for a particular platform. QLRA can provide specifications and guidance regarding electronic implementation.